GLI1 and neoplasm: It was recently demonstrated that selectively inhibiting HDAC1 and HDAC2 chemically decreases the tumor growth of SHH-MB in a murine model by inhibiting the Hedgehog pathway (Hh), which is further linked to an increase in GLI1 acetylation [16].